维普中文期刊产品整合服务

Use of methotrexate in inflammatory bowel disease in 2014: A User's Guide

查看全文 作  者:Arun [1,2]Swaminath;Raja [1]Taunk;Garrett [3]Lawlor 高影响力作者 机构地区:[1]IBD Program,NorthShore Hospital System,Lenox Hill Hospital,New York,NY 10075,United States;[2]Division of Gastroenterology,Lenox Hill Hospital,New York,NY 10075,United States;[3]NY Harbor Veteran’s Affairs Healthcare system,Brooklyn Campus,Brooklyn,NY 11201,United States高影响力机构 出  处:《World Journal of Gastrointestinal Pharmacology and Therapeutics》索引2014年第5卷第3期,共9页高影响力期刊 摘  要:Methotrexate has been used an immunomodulator in many autoimmune diseases,including inflammatory bowel disease. However,many physicians are unfamiliar or uncomfortable with its use in the management of inflammatory bowel disease. We summarize the data for use of methotrexate in common clinical scenarios:(1) steroid dependant Crohn's disease(CD);(2) maintenance of remission in steroid free CD;(3) azathioprine failures in CD;(4) in combination therapy with Anti-TNF agents in CD;(5) decreasing antibody formation to Anti-TNF therapy in CD;(6) management of fistulizing disease in CD; and(7) as well as induction and maintenance of remission in ulcerative colitis. An easy to use algorithm is provided for the busy clinician to access and safely prescribe methotrexate for their inflammatory bowel disease patients. 关 键 词:METHOTREXATE Inflammatory bowel DISEASE Crohn’s DISEASE ULCERATIVE COLITIS IMMUNOMODULATORS METHOTREXATE user’s GUIDE
相关文献

参考文献(1)

引证文献(4)

耦合文献(1)

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费